191 related articles for article (PubMed ID: 23426097)
1. The use of psychotropic agents for the symptoms of obsessive-compulsive disorder.
Brakoulias V; Starcevic V; Berle D; Milicevic D; Moses K; Hannan A; Sammut P; Martin A
Australas Psychiatry; 2013 Apr; 21(2):117-21. PubMed ID: 23426097
[TBL] [Abstract][Full Text] [Related]
2. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A
J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
[TBL] [Abstract][Full Text] [Related]
3. The characteristics of unacceptable/taboo thoughts in obsessive-compulsive disorder.
Brakoulias V; Starcevic V; Berle D; Milicevic D; Moses K; Hannan A; Sammut P; Martin A
Compr Psychiatry; 2013 Oct; 54(7):750-7. PubMed ID: 23587527
[TBL] [Abstract][Full Text] [Related]
4. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist.
Storch EA; Larson MJ; Price LH; Rasmussen SA; Murphy TK; Goodman WK
J Anxiety Disord; 2010 Aug; 24(6):650-6. PubMed ID: 20471199
[TBL] [Abstract][Full Text] [Related]
5. Rates and correlates of nonadherence to treatment in obsessive-compulsive disorder.
Santana L; Fontenelle JM; Yücel M; Fontenelle LF
J Psychiatr Pract; 2013 Jan; 19(1):42-53. PubMed ID: 23334678
[TBL] [Abstract][Full Text] [Related]
6. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
[TBL] [Abstract][Full Text] [Related]
7. Further support for five dimensions of obsessive-compulsive symptoms.
Brakoulias V; Starcevic V; Berle D; Sammut P; Milicevic D; Moses K; Hannan A; Martin A
J Nerv Ment Dis; 2013 Jun; 201(6):452-9. PubMed ID: 23686154
[TBL] [Abstract][Full Text] [Related]
8. Florida Obsessive-Compulsive Inventory: development, reliability, and validity.
Storch EA; Kaufman DA; Bagner D; Merlo LJ; Shapira NA; Geffken GR; Murphy TK; Goodman WK
J Clin Psychol; 2007 Sep; 63(9):851-9. PubMed ID: 17674398
[TBL] [Abstract][Full Text] [Related]
9. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist.
Sulkowski ML; Storch EA; Geffken GR; Ricketts E; Murphy TK; Goodman WK
J Clin Psychol; 2008 Dec; 64(12):1338-51. PubMed ID: 18942133
[TBL] [Abstract][Full Text] [Related]
10. Symptom structure of antipsychotic-induced obsessive compulsive symptoms in schizophrenia patients.
Kim JH; Ryu S; Nam HJ; Lim M; Baek JH; Joo YH; Kwon JS; Ha TH; Hong KS
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):75-9. PubMed ID: 22617280
[TBL] [Abstract][Full Text] [Related]
11. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
[TBL] [Abstract][Full Text] [Related]
12. Perceived parental rearing style in obsessive-compulsive disorder: relation to symptom dimensions.
Alonso P; Menchón JM; Mataix-Cols D; Pifarré J; Urretavizcaya M; Crespo JM; Jiménez S; Vallejo G; Vallejo J
Psychiatry Res; 2004 Jul; 127(3):267-78. PubMed ID: 15296826
[TBL] [Abstract][Full Text] [Related]
13. [Washing, checking, and rumination: are the belief domains, obsessions and compulsions specific to OCD subtypes?].
Kaiser B; Bouvard M; Milliery M
Encephale; 2010 Feb; 36(1):54-61. PubMed ID: 20159197
[TBL] [Abstract][Full Text] [Related]
14. Hoarding symptoms and prediction of poor response to limbic system surgery for treatment-refractory obsessive-compulsive disorder.
Gentil AF; Lopes AC; Dougherty DD; Rück C; Mataix-Cols D; Lukacs TL; Canteras MM; Eskandar EN; Larsson KJ; Hoexter MQ; Batistuzzo MC; Greenberg BD; Miguel EC
J Neurosurg; 2014 Jul; 121(1):123-30. PubMed ID: 24702323
[TBL] [Abstract][Full Text] [Related]
15. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition.
Storch EA; Rasmussen SA; Price LH; Larson MJ; Murphy TK; Goodman WK
Psychol Assess; 2010 Jun; 22(2):223-32. PubMed ID: 20528050
[TBL] [Abstract][Full Text] [Related]
16. [Hungarian translation of the Dimensional Yale-Brown Obsessive-Compulsive Scale and our first experiences with the test].
Harsányi A; Csigó K; Demeter G; Rajnai C; Németh A; Racsmány M
Psychiatr Hung; 2009; 24(1):18-59. PubMed ID: 19542567
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
Poyurovsky M; Faragian S; Shabeta A; Kosov A
Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
[TBL] [Abstract][Full Text] [Related]
18. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
[TBL] [Abstract][Full Text] [Related]
19. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity.
Scahill L; Riddle MA; McSwiggin-Hardin M; Ort SI; King RA; Goodman WK; Cicchetti D; Leckman JF
J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):844-52. PubMed ID: 9183141
[TBL] [Abstract][Full Text] [Related]
20. Personality dimensions in obsessive-compulsive disorder: relation to clinical variables.
Alonso P; Menchón JM; Jiménez S; Segalàs J; Mataix-Cols D; Jaurrieta N; Labad J; Vallejo J; Cardoner N; Pujol J
Psychiatry Res; 2008 Jan; 157(1-3):159-68. PubMed ID: 17900706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
